Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals

BJ Nolan; S Zwickl; AFQ Wong; P Locke; S Simpson; L Li; JD Zajac; AS Cheung

Journal article

Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals

BJ Nolan, S Zwickl, AFQ Wong, P Locke, S Simpson, L Li, JD Zajac, AS Cheung

Therapeutic Advances in Endocrinology and Metabolism | SAGE PUBLICATIONS LTD | Published : 2022

DOI: 10.1177/20420188221083512

Download PDF

Abstract

Background: Masculinising hormone therapy with testosterone is used to align an individual’s physical characteristics with their gender identity. Standard testosterone doses and formulations recommended for hypogonadal cisgender men are typically administered, although there are currently limited data evaluating the use of 1% testosterone gel in gender-affirming hormone therapy regimens. Objectives: The objective of the study was to assess the prescription patterns and serum total testosterone concentrations achieved with 1% testosterone gel in trans and gender diverse individuals. Materials and Methods: A retrospective cross-sectional analysis was undertaken of trans individuals at a primar..

View full abstract

University of Melbourne Researchers

Related Projects (2)

EFFECTS OF TESTOSTERONE AND OESTROGEN ON BODY COMPOSITION

Masculinising and feminising hormones such as testosterone and oestrogen respectively are important hormones controlling the amount of muscl..

Safety and quality of life of peri-operative transdermal estradiol continuation during gender affirmation surgery in transgender women: a randomised placebo-controlled trial

Despite no clear evidence, transgender women are told to stop their feminising estrogen treatment several weeks before gender surgery, but t..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: BJN is a recipient of an Australian Government National Health and Medical Research Council Postgraduate Scholarship (#2003939). ASC is supported by a National Health and Medical Research Council Early Career Fellowship (#1143333) and Investigator Grant (#2008956).